News | Radiology Business | January 25, 2024

A new logo and the new “Health with Care” payoff, to convey innovation and technology with empathy

Franco Fontana

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity at the 2024 Worldwide Sales & Marketing Meeting in Florence. Every year, about 400 managers, sales partners and stakeholders from 100 countries around the world converge at the event to share results, strategies and new technologies.

Together with the extraordinary renewal in all areas – products, infrastructure, business and organizational models – that has occurred in these last few years of constant growth, Esaote has decided to revise its brand identity to align with its vision, mission and core values.

The entire restyling process was undertaken with the aim of creating a more modern logo – an expression of science, innovation and technology – and to use all the elements that comprise the brand identity to put across the sense of care, empathy and sensitivity with which Esaote approaches its everyday work and addresses its target audience, to improve people’s well-being.

The new logo maintains the same naming to leverage the company’s origins, with new features added: new colors, subtle and minimalistic graphic elements, to express the Company’s mission of “Complexity is Simple”, and its new payoff of “Health with Care”.

“Our idea of care represents the common thread in our research and production processes and is expressed by Esaote's attention to the quality of its products. We constantly think about how to improve the diagnostic experience and how to integrate it into the more complex process of people's health, which goes from prevention to diagnosis and follow-up”, says Franco Fontana, Esaote CEO. “Esaote’s identity, which has evolved over its 40 years of existence, continues to uphold the company’s name, history and values. So much has changed in our evolutionary process, but our spirit has remained the same: as in the early days, our focus is on care and our commitment is to continue to explore new frontiers in science and technology”.

As a gateway to promote its new brand identity, Esaote has also completely revamped its website, www.esaote.com.  In addition to a transformed information architecture that greatly facilitates access to content, it features a life-centric approach, where people and their relationships are at the core of all processes.

For more information: www.esaote.com


Related Content

News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Breast Imaging

Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...

Time March 03, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
Subscribe Now